NeuroSense Therapeutics Ltd. (NRSN)
Nasdaq: NRSN · Pharmaceutical Preparations · Herzliya, IL · filing with the SEC since 2021
Who runs NeuroSense Therapeutics Ltd.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Ben-Noon Alon
Chief Executive Officer. First filing Mar 2026, latest Jun 17, 2026, 1 filing in all.
Officers reporting now
5
of 10 people with a filing in the last fifteen months
Directors reporting now
5
10 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Ben-Noon Alon | Chief Executive Officer | Mar 2026 | Jun 17, 2026 | none |
| Eisenberg Or | Chief Financial Officer | Mar 2026 | Jun 17, 2026 | none |
| Russek-Blum Niva | Chief Technology Officer | Mar 2026 | Mar 30, 2026 | none |
| Binder Hagit | General Manager | Mar 2026 | Mar 30, 2026 | none |
| Tracik Ferenc | Chief Medical Officer | Mar 2026 | Mar 18, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Mandil-Levin Revital | director | Mar 2026 | Mar 31, 2026 | none |
| Claiborne Cary J | director | Mar 2026 | Mar 18, 2026 | none |
| Golan Roy | director | Mar 2026 | Mar 18, 2026 | none |
| Leuchtenberger Mark | director | Mar 2026 | Mar 18, 2026 | none |
| Pellizzari Christine A | director | Mar 2026 | Mar 18, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.